Loading...
Loading...
Application UK00917045972 · Registered
| Application Number | UK00917045972 |
| Status | Registered |
| Owner | SENOLYTIC THERAPEUTICS, INC |
| Filed | 2017-07-28 |
| Registered | 2017-11-17 |
| Renewal Due | 2027-07-28 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. SENOLYTX is currently a registered UK trademark, with renewal due on 2027-07-28. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Cosmetics; Cosmetics for animals; Skincare cosmetics; Anti-aging moisturizers used as cosmetics; Cosmetics and cosmetic preparations.
Veterinary preparations and substances; Pharmaceutical preparations; Pharmaceutical preparations for veterinary use; Biopharmaceuticals for the treatment of cancer; Compounds for treating cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Diagnostic preparations; Diagnostic radiopharmaceutical preparations; Indicators for medical diagnosis; Medical diagnostic reagents; Reactants for veterinary diagnosis; Diagnostic preparations for medical or veterinary purposes; Diagnostic chemical reagents for medical use; Diagnostic preparations for medical purposes; Clinical diagnostic reagents; Clinical medical reagents; Reagents for medical use; Reagents for microbiological analysis [for medical purposes]; Reagents for use in analysis [for medical purposes]; Sanitary preparations for medical use; Chemical reagents for medical use; Diagnostic biomarker reagents for medical purposes.
Testing of cosmetics; Biological research, clinical research and medical research; Development of pharmaceutical preparations and medicines; Scientific research for medical purposes in the area of cancerous diseases; Scientific investigations for medical purposes; Scientific research for medical purposes; Scientific research in the field of pharmacy; Pharmaceutical research services; Consultancy relating to research and development in the field of therapeutics; Consultancy relating to research in the field of pharmacogenetics; Consultancy relating to pharmaceutical research and development; Scientific research and development; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Research and development for the pharmaceutical industry; Pharmaceutical drug development services; Provision of information and data relating to medical and veterinary research and development; Biomedical research services; Laboratory research services relating to pharmaceuticals; Scientific research relating to cosmetics; Computer aided diagnostic testing services; Chemical analysis services for use in evaluation; Conducting early evaluations in the field of new pharmaceuticals; Scientific and industrial research; Consultancy in the field of scientific research; Blood analysis services for scientific research purposes; Preparation of reports relating to scientific research; Computer aided scientific research services; Provision of information relating to scientific research; Scientific and technological services; Clinical trials; Conducting clinical trials; Conducting clinical trials for pharmaceutical products; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing information about the results of clinical trials for pharmaceutical products; Research relating to medicines; Research and development of vaccines and medicines.
Cosmetic analysis; Cosmetician services; Electrolysis for cosmetic purposes; Consultancy relating to cosmetics; Medical services; Provision of medical services; Medical analysis services; Laboratory analysis services relating to the treatment of persons; Healthcare services; Medical analysis services for the diagnosis of cancer; Medical analysis for the diagnosis and treatment of persons; Medical analysis services relating to the treatment of persons; Medical analysis services for cancer diagnosis and prognosis; Medical laboratory services for the analysis of samples taken from patients; Medical analysis services relating to the treatment of persons provided by a medical laboratory; Consultancy and information services relating to pharmaceutical products; Veterinary services; Information services relating to veterinary pharmaceuticals; Performing diagnosis of diseases; Surgical diagnostic services; RNA or DNA analysis for cancer diagnosis and prognosis.
'SENOLYTX' is a registered trademark on the UK IPO register, owned by SENOLYTIC THERAPEUTICS, INC. The application (UK00917045972) was filed on 28 July 2017 and registered on 17 November 2017. The registration is set to expire on 28 July 2027.
This mark is recorded under multiple classes: Class 3 (cosmetics, cleaning preparations & perfumery); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Francisco Javier Merino Villoria.
UK trademark UK00917045972 for the mark 'SENOLYTX' in Class 3, 5, 42, 44 is recorded on the UK IPO register as owned by SENOLYTIC THERAPEUTICS, INC. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00917045972 for the mark 'SENOLYTX' as registered.
UK trademark UK00917045972 for the mark 'SENOLYTX' is recorded in Class 3 (cosmetics, cleaning preparations & perfumery); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 3: Cosmetics; Cosmetics for animals; Skincare cosmetics; Anti-aging moisturizers used as cosmetics; Cosmetics and cosmetic preparations. | Class 5: Veterinary preparations and substances; Pharmaceutical preparations; Pharmaceutical preparations for veterinary use; Biopharmaceuticals for the treatment of cancer…
UK trademark UK00917045972 for the mark 'SENOLYTX' was filed at the UK IPO on 28 July 2017 and registered on 17 November 2017.
UK trademark UK00917045972 for the mark 'SENOLYTX' is currently recorded as valid until 28 July 2027, at which point it will need to be renewed with the UK IPO to remain in force.
Francisco Javier Merino Villoria is listed as the attorney / representative of record for UK trademark UK00917045972 for the mark 'SENOLYTX' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "SENOLYTX" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| SENOLYTXSame applicant | 79235652 | 602 | 2018-01-16 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.